Therefore, the aim of the present study was to investigate, for the first time, the role of Bcl-2:beclin-1 in “switching” between apoptosis and autophagy in glioma cells using the combined action of LY294002 and sorafenib. The gene discussed is BECN1; the disease is glioma.